2023\u20132024 Procedural Volume<\/h3>\n\n- 734<\/strong> total cardiovascular surgeries<\/li>\n
- 310<\/strong> open-heart surgeries<\/li>\n
- 94<\/strong> isolated CABG \u2014 off-pump rate 83%<\/strong><\/li>\n
- 40<\/strong> robotic MICS (fully endoscopic)<\/li>\n
- 65<\/strong> acute aortic dissections (Stanford type A, all emergency cases)<\/li>\n
- 97<\/strong> endovascular aortic procedures (TEVAR + EVAR)<\/li>\n<\/ul>\n
\n
\n View full clinical outcomes \u2192
\n <\/a>\n <\/p>\n<\/p><\/div>\n\nWhat this means for you<\/h3>\n\n- No waiting list \u2014 treatment can begin within one week<\/li>\n
- Integrated care by a single team across surgical and catheter-based treatment<\/li>\n
- 24\/7 emergency response for acute cardiovascular conditions<\/li>\n
- Treatment plans are clarified at an early stage<\/li>\n
- Second opinions are available for complex cases<\/li>\n<\/ul><\/div>\n<\/p><\/div>\n<\/section>\n
<\/p>\n\nAbout Us<\/h2>\n\nWe provide surgical care across the full spectrum of cardiovascular disease \u2014 from coronary artery disease and valvular heart disease to aortic conditions requiring emergency intervention.<\/p>\n
Our team performs open-heart surgery, endovascular aortic repair (TEVAR \/ EVAR), and robotic minimally invasive cardiac surgery (MICS)<\/strong>.
\n When both catheter-based and surgical options are appropriate, treatment planning is discussed with the patient based on clinical findings, risk, and individual preference.<\/p>\nCardiovascular surgery is available 24\/7<\/strong>, with a firm policy of not turning patients away.<\/p>\n<\/p><\/div>\n<\/section>\n<\/p>\n\nClinical Leadership<\/h2>\n\n ![\"Satoshi](\"\/en\/wp-content\/uploads\/2026\/03\/kuroyanagi.jpg\"\n)
<\/p>\n\nSatoshi Kuroyanagi, M.D., Ph.D.<\/h2>\n
President & Senior Cardiovascular Surgeon
Kishiwada Tokushukai Hospital<\/p>\n<\/p><\/div>\n<\/div>\n
Cardiovascular care at this hospital is led by Dr. Kuroyanagi, who serves as both President and senior cardiovascular surgeon.
\n He oversees clinical decision-making from initial evaluation through treatment and follow-up, ensuring clear medical responsibility throughout care.<\/p>\n
Full profile \u2192<\/a><\/p>\n<\/section>\n<\/p>\n\nServices<\/h2>\n\n\n Heart valve disease (including TAVI)<\/a>\n <\/div>\n
\n <\/p>\n We provide surgical care across the full spectrum of cardiovascular disease \u2014 from coronary artery disease and valvular heart disease to aortic conditions requiring emergency intervention.<\/p>\n Our team performs open-heart surgery, endovascular aortic repair (TEVAR \/ EVAR), and robotic minimally invasive cardiac surgery (MICS)<\/strong>. Cardiovascular surgery is available 24\/7<\/strong>, with a firm policy of not turning patients away.<\/p>\n<\/p><\/div>\n<\/section>\n <\/p>\n President & Senior Cardiovascular Surgeon Cardiovascular care at this hospital is led by Dr. Kuroyanagi, who serves as both President and senior cardiovascular surgeon. Full profile \u2192<\/a><\/p>\n<\/section>\n <\/p>\n
\n View full clinical outcomes \u2192
\n <\/a>\n <\/p>\n<\/p><\/div>\nWhat this means for you<\/h3>\n
\n
About Us<\/h2>\n
\n When both catheter-based and surgical options are appropriate, treatment planning is discussed with the patient based on clinical findings, risk, and individual preference.<\/p>\nClinical Leadership<\/h2>\n
<\/p>\nSatoshi Kuroyanagi, M.D., Ph.D.<\/h2>\n
Kishiwada Tokushukai Hospital<\/p>\n<\/p><\/div>\n<\/div>\n
\n He oversees clinical decision-making from initial evaluation through treatment and follow-up, ensuring clear medical responsibility throughout care.<\/p>\nServices<\/h2>\n